{
  "title": "Paper_1125",
  "abstract": "pmc Toxins (Basel) Toxins (Basel) 1577 toxins toxins Toxins 2072-6651 Multidisciplinary Digital Publishing Institute  (MDPI) PMC12474036 PMC12474036.1 12474036 12474036 41003496 10.3390/toxins17090431 toxins-17-00431 1 Article Extract of Indigofera spicata https://orcid.org/0000-0001-7803-3900 Shuvayeva Galyna Methodology Investigation Writing – original draft Writing – review & editing Visualization 1 https://orcid.org/0000-0002-9880-0983 Tupychak Mykola Methodology Investigation 2 https://orcid.org/0000-0001-6703-457X Vovk Olena Investigation Resources 1 https://orcid.org/0000-0002-1378-8402 Demash Dmytro Software Visualization 1 Chernyshuk Svitlana Investigation 1 Bobak Yaroslav Methodology Investigation 1 † https://orcid.org/0000-0003-1690-4090 Prokopiv Andriy Methodology Resources 3 4 https://orcid.org/0000-0001-8222-5008 Pokhodylo Nazariy Conceptualization Supervision Funding acquisition 2 5 https://orcid.org/0000-0003-3912-6594 Kunz-Schughart Leoni A. Conceptualization Resources Writing – review & editing 6 7 https://orcid.org/0000-0003-0189-3376 Fletcher Mary T. 8 Stasyk Oleh Conceptualization Writing – original draft Writing – review & editing Supervision Funding acquisition 1 9 * 1 shuvayeva77@gmail.com vovkoliv@gmail.com ddemash@gmail.com s.chernyshu@ukr.net bobakyaroslav@gmail.com 2 tupychakmykola@gmail.com pokhodylo@gmail.com 3 prokopivandriy1@gmail.com 4 5 6 leoni.kunz-schughart@oncoray.de 7 8 mary.fletcher@uq.edu.au 9 * stasyk@cellbiol.lviv.ua olehst11@gmail.com † Y. Bobak died in 2023. 29 8 2025 9 2025 17 9 497674 431 20 7 2025 25 8 2025 27 8 2025 29 08 2025 27 09 2025 28 09 2025 © 2025 by the authors. 2025 https://creativecommons.org/licenses/by/4.0/ Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ( https://creativecommons.org/licenses/by/4.0/ Metabolic anticancer therapy based on enzymatic arginine (Arg) deprivation (ADT) is currently being evaluated in clinical trials. The combination of ADT with low doses of the plant cytotoxic analogs of Arg, canavanine (Cav) or indospicine (Isp), have been proposed as being more efficient and selective against malignant cells. The leguminous plant Indigofera spicata I. spicata indospicine Indigofera spicata metabolic anticancer therapy arginine deprivation “Presidential Discretionary-Ukraine Support Grants” from Simons Foundation SFI-PD-Ukraine-00014576 National Research Foundation of Ukraine (NRFU) project N 2023.04/0048 0124U003831 BMBF/BMFTR 01DK24023 MES of Ukraine 0124U003964 This study was partially supported by “Presidential Discretionary-Ukraine Support Grants” from Simons Foundation, SFI-PD-Ukraine-00014576. The work was also supported in part by the National Research Foundation of Ukraine (NRFU) project N 2023.04/0048, State registration number 0124U003831, «Development of a broad-spectrum antimicrobial agent based on the extract of the leguminous plant Indigofera spicata pmc-status-qastatus 0 pmc-status-live yes pmc-status-embargo no pmc-status-released yes pmc-prop-open-access yes pmc-prop-olf no pmc-prop-manuscript no pmc-prop-legally-suppressed no pmc-prop-has-pdf yes pmc-prop-has-supplement yes pmc-prop-pdf-only no pmc-prop-suppress-copyright no pmc-prop-is-real-version no pmc-prop-is-scanned-article no pmc-prop-preprint no pmc-prop-in-epmc yes Key Contribution I. spicata 1. Introduction Arginine (Arg) is a functionally versatile amino acid and is semi-essential in humans [ 1 2 3 2 4 5 6 7 8 9 10 11 12 13 5 3 11 12 13 We have previously reported on the selective anticancer effect of low micromolar doses of canavanine (Cav), a structural Arg analog of plant origin (e.g., from Canavalia ensiformis 14 14 15 15 16 Therefore, we searched for an alternative Arg analog in plants that is unlikely to be degraded by rhARGI and identified indospicine. L-indospicine (2(S)-2,7-diamino-7-iminoheptenic acid, Isp) is a natural Arg proteomimetic analog which differs from Arg by a single substitution of the nitrogen atom to carbon in position 6 of its backbone ( Figure S1 17 Isp is found only in leguminous subtropical plants of the genus Indigofera 18 16 16 Unfortunately, pure Isp is not readily available, neither through synthesis nor isolation from plant sources. However, we hypothesized that Isp-containing plant extracts may serve as a readily available substitute for pure Isp, which may for instance be applied for treating localized or physically accessible tumors. Isp has been found in a number of leguminous Indigofera I. spicata I. linnaei 18 19 I. spicata 19 I. linnaei Here, we report for the first time that crude Isp-bearing ethanolic extracts of the perennial legume I. spicata 2. Results 2.1. Preparation of the Isp-Containing Extracts from Dried Biomass (Seedpods) of I. spicata Mature I. spicata 20 21 Indigofera 22 Indigofera 19 23 I. spicata Figure 1 I. spicata 25 26 Figure 2 We observed a purple/violet TLC spot at Rf = 0.69 after ninhydrin visualisation, corresponding to co-eluting standard Isp ( Figure 3 Figure 2 I. spicata Figure 2 27 28 I.spicata 19 23 29 I. spicata Figure 3 2.2. Impact of I. spicata Extract on the Viability of Human Carcinoma Cells Human colorectal carcinoma HCT-116 and ovarian carcinoma SKOV3 cells were applied as experimental models for assessing the cytotoxicity of the I. spicata Figure 4 15 16 30 14 30 50 16 I. spicata Figure 4 16 I. spicata Figure 4 I. spicata Figure S2 2.3. Effect of I. spicata Extract on the Residual Proliferative Potential of Cancer Cells One of the aspects of the cancer cells’ sensitivity to ADT in vitro is their ability to restore proliferation when AFM medium is replaced by fresh Arg-containing CM, reflecting their “residual proliferative potential”. To evaluate this capacity for growth recovery, cells were exposed to the various treatment conditions for 72 h, followed by the substitution of the supernatant with Arg-rich CM for an additional 72 h, post-treatment exposure time. As seen in Figure 5 I. spicata I. spicata Figure 5 2.4. Antiproliferative Effect of I. spicata Extract in Combination with rhARGI Finally, we addressed whether the I. spicata Figure 6 I. spicata Figure 6 3. Discussion We have reported in previous studies that Isp is selectively toxic in mid-micromolar doses for malignant cells when cultured as monolayers in medium depleted of Arg [ 16 14 16 16 10 31 32 33 34 35 In the present work, we aimed to determine whether amino acid-bearing ethanolic extracts of I. spicata I. spicata 19 Consistent with previous literature reporting that seeds of I. spicata 36 I. spicata 37 38 Notably, pre-treatment of the extract with rhARGI did not alter the extract’s antiproliferative efficacy in our model cancer cells, supporting the notion that the approach offers promise for therapeutic combination. Indeed, our data suggest that the I. spicata Importantly, exposure to I. spicata I. spicata I. spicata As mentioned above, since pure Isp is difficult to obtain, our data emphasize an interesting and reasonable alternative with cancericidal efficacy in the form of I. spicata I. linnaei 19 I. spicata 20 Figure 1 4. Conclusions In this article, we evaluated the antiproliferative effects of an ethanolic extract of the leguminous plant I. spicata 5. Materials and Methods 5.1. Reagents Dulbecco’s Modified Eagle Medium (DMEM), selective amino acids-deficient DMEM, fetal bovine serum (FBS), dialyzed FBS, gentamycin, L-arginine monohydrochloride (Arg), L-methionine, L-leucine, and L-lysine monohydrochloride were purchased from Sigma-Aldrich (St. Louis, MO, USA), PAN-Biotech (Aidenbach, Germany), CytivaHyClone (Logan, UT, USA), or Merck (Darmstadt, Germany). Pure indospicine was provided by Prof Fletcher, with the synthesis previously described [ 17 Ogataea polymorpha 5.2. Cell Lines and Culture Conditions Human colorectal carcinoma HCT-116 and ovarian carcinoma SKOV3 cells used in this work were obtained from the ATCC (Manassas, VA, USA). All cell cultures tested negative for mycoplasma contamination with MycoAlert (Cambrex Bio Science Rockland, Inc, ME, USA) and PCR Mycoplasma Test (Applichem, Darmstadt, Germany) kits prior to use. Cells were routinely incubated in DMEM supplemented with 10% FBS, 50 mg/l gentamicin and 2 мM glutamine at 37 °C in a humidified atmosphere with 5% CO 2 16 5.3. Cell Viability Detection by the MTT Assay For the evaluation of the effect of various experimental (treatment) conditions on cell viability, cells were initially seeded at 2 × 10 4 5.4. Preparation of Plant Extracts from I. spicata I. spicata I. spicata I. spicata 23 The resulting extracts were filtered through Schott filters of different pore sizes and concentrated in rotary evaporator under lowered pressure and temperatures below 40 °C until the concentrated extract volume was around 2 mL. In the case of a low dispersed precipitate being observed, it was removed by centrifugation. The concentrated extract was diluted in PBS in a volumetric flask to a final constant volume (100 mL), filter sterilized and stored at 4 °C. 5.5. Thin Layer Chromatography of Extracts from I. spicata Amino acids of interest were identified by thin layer chromatography (TLC) according to [ 25 26 254 v v 5.6. LC-MS Analysis of Extracts from I. spicata The analysis was performed using an Agilent 1100 LC/MSD system with a Poroshell 120 SB-C18 column (4.6 × 30 mm, 2.7 µm) at 60 °C. Mobile phase: water with 0.1% formic acid and acetonitrile with 0.1% formic acid, gradient from 1% to 100% B over 1.5 min. Scan range: 83–1000 m z + m z 7 16 3 2 + Figure 3 5.7. Statistical Analysis Mean values ± SD from repeated, independent experiments ( n t p Disclaimer/Publisher’s Note: Supplementary Materials The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/toxins17090431/s1 Author Contributions Conceptualization, O.S., N.P., L.A.K.-S. and M.T.F.; methodology, G.S., M.T., A.P. and Y.B.; software, D.D.; investigation, G.S., M.T., S.C., O.V. and Y.B.; resources, O.V., A.P., M.T.F. and L.A.K.-S.; writing—original draft preparation, G.S. and O.S.; writing—review and editing, G.S., M.T.F., O.S. and L.A.K.-S.; visualization, G.S. and D.D.; supervision, M.T.F., N.P. and O.S.; funding acquisition, N.P., M.T.F. and O.S. All authors have read and agreed to the published version of the manuscript. Institutional Review Board Statement Not applicable. Informed Consent Statement Not applicable. Data Availability Statement The data presented in this study are available on request from the corresponding author due to legal restrictions that concern some of the dataset or materials. Conflicts of Interest The authors declare no conflicts of interest. References 1. Morris S.M. Jr. Arginine: Beyond protein Am. J. Clin. Nutr. 2006 83 508s 512s 10.1093/ajcn/83.2.508S 16470022 2. Chen C.-L. Hsu S.-C. Ann D.K. Yen Y. Kung H.-J. Arginine Signaling and Cancer Metabolism Cancers 2021 13 3541 10.3390/cancers13143541 34298755 PMC8306961 3. Field G.C. Pavlyk I. Szlosarek P.W. Bench-to-Bedside Studies of Arginine Deprivation in Cancer Molecules 2023 28 2150 10.3390/molecules28052150 36903394 PMC10005060 4. Chu Y.D. Lai M.W. Yeh C.T. Unlocking the Potential of Arginine Deprivation Therapy: Recent Breakthroughs and Promising Future for Cancer Treatment Int. J. Mol. Sci. 2023 24 10668 10.3390/ijms241310668 37445845 PMC10341449 5. Anakha J. Kawathe P.S. Datta S. Jawalekar S.S. Banerjee U.C. Pande A.H. Human arginase 1, a Jack of all trades? 3 Biotech 2022 12 264 10.1007/s13205-022-03326-9 PMC9450830 36082360 6. Endicott M. Jones M. Hull J. Amino acid metabolism as a therapeutic target in cancer: A review Amino Acids 2021 53 1169 1179 10.1007/s00726-021-03052-1 34292410 PMC8325646 7. Ascierto P.A. Scala S. Castello G. Daponte A. Simeone E. Ottaiano A. Beneduce G. De Rosa V. Izzo F. Melucci M.T. Pegylated Arginine Deiminase Treatment of Patients with Metastatic Melanoma: Results From Phase I and II Studies J. Clin. Oncol. 2005 23 7660 7668 10.1200/JCO.2005.02.0933 16234528 8. Glazer E.S. Piccirillo M. Albino V. Di Giacomo R. Palaia R. Mastro A.A. Beneduce G. Castello G. De Rosa V. Petrillo A. Phase II Study of Pegylated Arginine Deiminase for Nonresectable and Metastatic Hepatocellular Carcinoma J. Clin. Oncol. 2010 28 2220 2226 10.1200/JCO.2009.26.7765 20351325 9. Yang T.S. Lu S.N. Chao Y. Sheen I.S. Lin C.C. Wang T.E. Chen S.C. Wang J.H. Liao L.Y. Thomson J.A. A randomised phase II study of pegylated arginine deiminase (ADI-PEG 20) in Asian advanced hepatocellular carcinoma patients Br. J. Cancer 2010 103 954 960 10.1038/sj.bjc.6605856 20808309 PMC2965867 10. Yau T. Cheng P.N. Chan P. Chan W. Chen L. Yuen J. Pang R. Fan S.T. Poon R.T. A phase 1 dose-escalating study of pegylated recombinant human arginase 1 (Peg-rhArg1) in patients with advanced hepatocellular carcinoma Investig. New Drugs 2013 31 99 107 10.1007/s10637-012-9807-9 22426640 PMC3553413 11. Savaraj N. Wu C. Li Y.Y. Wangpaichitr M. You M. Bomalaski J. He W. Kuo M.T. Feun L.G. Targeting argininosuccinate synthetase negative melanomas using combination of arginine degrading enzyme and cisplatin Oncotarget 2015 6 6295 6309 10.18632/oncotarget.3370 25749046 PMC4467438 12. Liu J. Ma J. Wu Z. Li W. Zhang D. Han L. Wang F. Reindl K.M. Wu E. Ma Q. Arginine deiminase augments the chemosensitivity of argininosuccinate synthetase-deficient pancreatic cancer cells to gemcitabine via inhibition of NF-κB signaling BMC Cancer 2014 14 686 10.1186/1471-2407-14-686 25240403 PMC4189535 13. Bean G.R. Kremer J.C. Prudner B.C. Schenone A.D. Yao J.-C. Schultze M.B. Chen D.Y. Tanas M.R. Adkins D.R. Bomalaski J. A metabolic synthetic lethal strategy with arginine deprivation and chloroquine leads to cell death in ASS1-deficient sarcomas Cell Death Dis. 2016 7 e2406 10.1038/cddis.2016.232 PMC5133958 27735949 14. Bobak Y. Kurlishchuk Y. Vynnytska-Myronovska B. Grydzuk O. Shuvayeva G. Redowicz M.J. Kunz-Schughart L.A. Stasyk O. Arginine deprivation induces endoplasmic reticulum stress in human solid cancer cells Int. J. Biochem. Cell Biol. 2016 70 29 38 10.1016/j.biocel.2015.10.027 26546743 15. Kurlishchuk Y. Vynnytska-Myronovska B. Grosse-Gehling P. Bobak Y. Manig F. Chen O. Merker S.R. Henle T. Löck S. Stange D.E. Co-application of canavanine and irradiation uncouples anticancer potential of arginine deprivation from citrulline availability Oncotarget 2016 7 45 10.18632/oncotarget.12320 PMC5341980 27689335 16. Shuvayeva G.Y. Bobak Y.P. Vovk O.I. Kunz-Schughart L.A. Fletcher M.T. Stasyk O.V. Indospicine combined with arginine deprivation triggers cancer cell death via caspase-dependent apoptosis Cell Biol. Int. 2021 45 518 527 10.1002/cbin.11321 32068315 17. Lang C.-S. Wong S.-H. Chow S. Challinor V.L. Yong K.W.L. Fletcher M.T. Arthur D.M. Ng J.C. De Voss J.J. Synthesis of l-indospicine, [5,5,6- 2 3 Org. Biomol. Chem. 2016 14 6826 6832 10.1039/C6OB01187J 27338015 18. Salmon S.E. Hall S.L. Phillips D.E. Dries L.R. Sarandopoulos J. Coghill A. Hawes M.C. Hepatopathy in Victorian dogs consuming pet meat contaminated with indospicine Aust. Vet. J. 2022 100 465 475 10.1111/avj.13171 35982633 PMC9805164 19. Tan E.T.T. Materne C.M. Silcock R.G. D’Arcy B.R. Al Jassim R. Fletcher M.T. Seasonal and Species Variation of the Hepatotoxin Indospicine in Australian Indigofera Legumes As Measured by UPLC-MS/MS J. Agric. Food Chem. 2016 64 6613 6621 10.1021/acs.jafc.6b02437 27509381 20. Plants of the World Online Available online: https://powo.science.kew.org/taxon/urn:lsid:ipni.org:names:500027-1 (accessed on 17 August 2025) 21. Australian Plant Census (APC) Council of Heads of Australian Herbaria Available online: http://www.anbg.gov.au/chah/apc/index.html (accessed on 17 August 2025) 22. Wilson P. Rowe R. A revision of the Indigofereae (Fabaceae) in Australia. 2. Indigofera species with trifoliolate and alternately pinnate leaves Telopea 2008 12 293 307 10.7751/telopea20085819 23. Aylward J.H. Court R.D. Haydock K.P. Strickland R.W. Hegarty M.P. Indigofera species with agronomic potential in the tropics. Rat toxicity studies Aust. J. Agric. Res. 1987 38 177 186 10.1071/AR9870177 24. Tool B.C.C.W.I. Creeping Indigo Available online: https://weeds.brisbane.qld.gov.au/weeds/creeping-indigo (accessed on 17 August 2025) 25. Baranowska I. Markowski P. Wilczek A. Szostek M. Stadniczuk M. Normal and Reversed-Phase Thin-Layer Chromatography in the Analysis of l-Arginine, its Metabolites, and Selected Drugs JPC J. Planar Chromatogr. Mod. TLC 2009 22 89 96 10.1556/JPC.22.2009.2.3 26. Bhawani S.A. Mohamad Ibrahim M.N. Sulaiman O. Hashim R. Mohammad A. Hena S. THIN-LAYER CHROMATOGRAPHY OF AMINO ACIDS: A REVIEW J. Liq. Chromatogr. Relat. Technol. 2012 35 1497 1516 10.1080/10826076.2011.619039 27. Stauß A.C. Fuchs C. Jansen P. Repert S. Alcock K. Ludewig S. Rozhon W. The Ninhydrin Reaction Revisited: Optimisation and Application for Quantification of Free Amino Acids Molecules 2024 29 3262 10.3390/molecules29143262 39064842 PMC11278723 28. Friedman M. Applications of the ninhydrin reaction for analysis of amino acids, peptides, and proteins to agricultural and biomedical sciences J. Agric. Food Chem. 2004 52 385 406 10.1021/jf030490p 14759124 29. Gardner D.R. Riet-Correa F. Analysis of the Toxic Amino Acid Indospicine by Liquid Chromatography-Tandem Mass Spectrometry Int. J. Poisonous Plant Res. 2011 1 20 27 30. Bobak Y.P. Vynnytska B.O. Kurlishchuk Y.V. Sibirny A.A. Stasyk O.V. Cancer cell sensitivity to arginine deprivation in vitro is not determined by endogenous levels of arginine metabolic enzymes Cell Biol. Int. 2010 34 1085 1089 10.1042/CBI20100451 20653567 31. Chan S.L. Cheng P.N.M. Liu A.M. Chan L.L. Li L. Chu C.M. Chong C.C.N. Lau Y.M. Yeo W. Ng K.K.C. A phase II clinical study on the efficacy and predictive biomarker of pegylated recombinant arginase on hepatocellular carcinoma Investig. New Drugs 2021 39 1375 1382 10.1007/s10637-021-01111-8 33856599 PMC8426309 32. Yau T. Cheng P.N.M. Chiu J. Kwok G.G.W. Leung R. Liu A.M. Cheung T.T. Ng C.T. A phase 1 study of pegylated recombinant arginase (PEG-BCT-100) in combination with systemic chemotherapy (capecitabine and oxaliplatin)[PACOX] in advanced hepatocellular carcinoma patients Investig. New Drugs 2022 40 314 321 10.1007/s10637-021-01178-3 34735674 33. Cheng P.N.M. Liu A.M. Bessudo A. Mussai F. Safety, PK/PD and preliminary anti-tumor activities of pegylated recombinant human arginase 1 (BCT-100) in patients with advanced arginine auxotrophic tumors Investig. New Drugs 2021 39 1633 1640 10.1007/s10637-021-01149-8 34287772 34. Mussai F. De Santo C. Cheng P. Thomas I.F. Ariti C. Upton L. Scarpa U. Stavrou V. Sydenham M. Burnett A.K. A randomised evaluation of low-dose Ara-C plus pegylated recombinant arginase BCT-100 versus low dose Ara-C in older unfit patients with acute myeloid leukaemia: Results from the LI-1 trial Br. J. Haematol. 2023 200 573 578 10.1111/bjh.18560 36413792 35. Szlosarek P.W. Wimalasingham A.G. Phillips M.M. Hall P.E. Chan P.Y. Conibear J. Lim L. Rashid S. Steele J. Wells P. Phase 1, pharmacogenomic, dose-expansion study of pegargiminase plus pemetrexed and cisplatin in patients with ASS1-deficient non-squamous non-small cell lung cancer Cancer Med. 2021 10 6642 6652 10.1002/cam4.4196 34382365 PMC8495293 36. Hegarty M.P. Pound A.W. Indospicine, a Hepatotoxic Amino Acid from Indigofera Spicat A: Isolation, Structure, and Biological Studies Aust. J. Biol. Sci. 1970 23 831 842 10.1071/BI9700831 37. Dabbousy R. Rima M. Roufayel R. Rahal M. Legros C. Sabatier J.-M. Fajloun Z. Plant Metabolomics: The Future of Anticancer Drug Discovery Pharmaceuticals 2024 17 1307 10.3390/ph17101307 39458949 PMC11510165 38. Pastuña-Fasso J.V. Quiroz-Moreno C.D. Medina-Villamizar E.J. Cooperstone J.L. Radice M. Peñuela-Mora M.C. Almeida J.R. Mogollón N.G.S. Metabolite fingerprinting of Urospatha sagittifolia (Araceae) tubers at different growth stages by multi-platform metabolomics and molecular networking Microchem. J. 2024 199 110058 10.1016/j.microc.2024.110058 Figure 1 I. spicata 24 a I. spicata b Figure 2 Thin layer chromatographic visualization of Isp in an I. spicata I. spicata Figure 3 LC-MS analysis of Indigofera spicata a b c m z d m z e m z Figure 4 Cell viability of human colorectal carcinoma HCT-116 ( a b I. spicata p p p p p p Figure 5 Residual proliferative potential assessed via MTT assays in HCT-116 ( a b w o I. spicata p p p Figure 6 Relative viability of HCT-116 colorectal carcinoma cells exposed to rhARGI-pretreated and non-pretreated extracts of I. spicata I. spicata p p p p p p ns ",
  "metadata": {
    "Title of this paper": "Metabolite fingerprinting of Urospatha sagittifolia (Araceae) tubers at different growth stages by multi-platform metabolomics and molecular networking",
    "Journal it was published in:": "Toxins",
    "URL": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12474036/"
  }
}